TRUL Stock Overview
Operates as a cannabis retailer. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Trulieve Cannabis Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$4.66 |
| 52 Week High | CA$20.00 |
| 52 Week Low | CA$4.30 |
| Beta | 1.65 |
| 1 Month Change | -22.72% |
| 3 Month Change | -36.68% |
| 1 Year Change | -69.94% |
| 3 Year Change | -79.74% |
| 5 Year Change | -63.54% |
| Change since IPO | -53.31% |
Recent News & Updates
Recent updates
Adult-Use Cannabis Expansion In Florida And Pennsylvania Will Broaden Markets
Mar 25 Strategic retail expansion and new market entry in key states could significantly boost revenue and market share by tapping into adult-use markets.Here's Why Trulieve Cannabis (CSE:TRUL) Has A Meaningful Debt Burden
Jan 10
More Unpleasant Surprises Could Be In Store For Trulieve Cannabis Corp.'s (CSE:TRUL) Shares After Tumbling 56%
Dec 05Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 47%?
Sep 04Trulieve Cannabis Corp.'s (CSE:TRUL) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 15Trulieve Cannabis Corp.'s (CSE:TRUL) CEO Will Probably Struggle To See A Pay Rise This Year
Jun 06Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 38%?
May 01Revenues Not Telling The Story For Trulieve Cannabis Corp. (CSE:TRUL) After Shares Rise 26%
Mar 31Is Trulieve Cannabis (CSE:TRUL) A Risky Investment?
Feb 15There's Reason For Concern Over Trulieve Cannabis Corp.'s (CSE:TRUL) Massive 29% Price Jump
Jan 16Calculating The Intrinsic Value Of Trulieve Cannabis Corp. (CSE:TRUL)
Mar 06These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Extensively
Jan 26Does Trulieve Cannabis (CSE:TRUL) Have A Healthy Balance Sheet?
Aug 07Are Trulieve Cannabis Corp. (CSE:TRUL) Investors Paying Above The Intrinsic Value?
Jul 03These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Reasonably Well
Mar 21Shareholder Returns
| TRUL | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 2.4% | -0.05% | 1.3% |
| 1Y | -69.9% | -63.8% | 5.3% |
Return vs Industry: TRUL underperformed the Canadian Pharmaceuticals industry which returned -63.7% over the past year.
Return vs Market: TRUL underperformed the Canadian Market which returned 5.3% over the past year.
Price Volatility
| TRUL volatility | |
|---|---|
| TRUL Average Weekly Movement | 7.5% |
| Pharmaceuticals Industry Average Movement | 12.3% |
| Market Average Movement | 9.4% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 3.9% |
Stable Share Price: TRUL has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: TRUL's weekly volatility has decreased from 13% to 7% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1940 | 6,000 | Kim Rivers | www.trulieve.com |
Trulieve Cannabis Corp. operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One brands.
Trulieve Cannabis Corp. Fundamentals Summary
| TRUL fundamental statistics | |
|---|---|
| Market cap | CA$890.09m |
| Earnings (TTM) | -CA$207.53m |
| Revenue (TTM) | CA$1.65b |
0.5x
P/S Ratio-4.3x
P/E RatioIs TRUL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRUL income statement (TTM) | |
|---|---|
| Revenue | US$1.19b |
| Cost of Revenue | US$470.75m |
| Gross Profit | US$715.75m |
| Other Expenses | US$865.15m |
| Earnings | -US$149.40m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 07, 2025
| Earnings per share (EPS) | -0.78 |
| Gross Margin | 60.32% |
| Net Profit Margin | -12.59% |
| Debt/Equity Ratio | 38.5% |
How did TRUL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/13 17:20 |
| End of Day Share Price | 2025/04/11 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Trulieve Cannabis Corp. is covered by 21 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aaron Grey | Alliance Global Partners |
| Kenric Tyghe | ATB Capital Markets |
| Frederico Yokota Choucair Gomes | ATB Capital Markets |